Ligand Q3 2026 royalty revenue up 51%
Ligand reported a 51% year-over-year increase in royalty revenue to $70.3 million and raised full-year Adjusted Diluted EPS guidance to $9.50 to $9.75. The results reflect performance from key assets like Filspari and the XOMA acquisition.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed